Answers are grounded in this paper and cite their sources.
Observational study reveals high initial pain relief after microvascular decompression in trigeminal neuralgia, indicating symptom duration and vessel count predict recurrence.
Objective: This study aims to share a single surgeon’s experience among patients with primary and secondary trigeminal neuralgia (TGN) managed with microvascular decompression (MVD), detailing immediate and last follow-up results and identifying the prognostic factors associated with various outcomes and recurrences. Methods: A retrospective observational analysis of 136 consecutive patients (78.2% primary, 21.8% secondary TGN) managed with MVD between June 2018 and January 2025, with at least 3 months of follow-up, was conducted. Surgical results, complications, and recurrence rates were reviewed along with factors affecting these outcomes. Results: A total of 101 patients were analyzed with a mean preoperative duration of symptoms of 4 years. V2V3 segment was the most common pain-harboring region. Superior cerebellar artery was the most common conflicting vessel. Immediate complete pain relief was achieved in 94.8% of cases (94.7% in primary and 95.2% in secondary TGN groups). At a mean latest follow-up of 266 (range: 10–2250 days) days, 84.2% of primary TGN and 95.2% of secondary TGN patients had experienced persistent pain relief (Barrow Neurological Institute [BNI] I). Poor immediate pain relief correlated strongly with poor outcomes at both first and final follow-up ( P < 0.001). The most frequent complication was facial hypoesthesia (19.6%). The recurrence rate at last follow-up was 31.6%. Redo MVD stood out as the most efficient treatment modality. Conclusion: MVD still enjoys being the most coherent management strategy for drug-resistant TGN, with age being no bar. Favorable outcomes with shorter preoperative duration prompt the need for increasing patient awareness, improving multidisciplinary communications, and expeditious referral to a neurosurgical unit to amplify the patient’s welfare. A duration of preoperative symptoms of more than 4 years, >2 vessels in conflict, and lack of immediate postoperative relief in symptoms herald the increased risk of pain recurrence.
No takes yet. Share an insight, caveat, or question.
Tripathi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: